Anti-EGFR Antibody–Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth

Overview of attention for article published in Clinical Cancer Research, May 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 19 news outlets
blogs: 2 blogs

twitter: 7 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 8 Mendeley

Summary News Blogs X Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

Article in Pharmaceutics (July 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.